Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

 Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

Shots:

  • Otsuka and Click have reported the initiation of the Mirai study which is a fully remote clinical trial to investigate the effectiveness of digital therapeutics in reducing depressive symptoms in adults diagnosed with MDD who are on antidepressant monotherapy. The study will enroll ~540 patients globally
  • The trial will run fully remotely utilizing the Verily Project Baseline platform, a first-of-its-kind trial design for MDD. Participation will be of 10wks. and efficacy will be evaluated as a change from baseline in the MADRS total score
  • The companies’ collaboration with Verily enables the trial to proceed efficiently and safely during the pandemic

Click here ­to­ read full press release/ article | Ref: Businesswire | Image: Contract Pharma

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post